US FDA Has Approved First GM Pig for People with Red Meat AllergiesDecember 16, 2020
"Today's first-ever approval of an animal biotechnology product for both food and as a potential source for biomedical use represents a tremendous milestone for scientific innovation," said FDA Commissioner Stephen M. Hahn, M.D. "As part of our public health mission, the FDA strongly supports advancing innovative animal biotechnology products that are safe for animals, safe for people, and achieve their intended results. Today's action underscores the success of the FDA in modernizing our scientific processes to optimize a risk-based approach that advances cutting-edge innovations in which consumers can have confidence."
GalSafe pigs may potentially provide a source of porcine-based materials to produce human medical products that are free of detectable alpha-gal sugar. For example, GalSafe pigs could potentially be used as a source of the blood-thinning drug heparin, free of detectable alpha-gal sugar. Tissues and organs from GalSafe pigs could potentially address the issue of immune rejection in patients receiving xenotransplants, as alpha-gal sugar is believed to be a cause of rejection in patients.
As part of its review, the FDA evaluated the safety of IGA for animals and humans eating meat from them, as well as the product developer's intention to market the IGA for its ability to eliminate alpha-gal sugar on pigs' cells. The FDA determined that food from GalSafe pigs is safe for the general population to eat. The FDA's review also ensured that there is no detectable level of alpha-gal sugar across multiple generations of GalSafe pigs.
For more details about this approval, read the FDA news release.
You might also like:
- Most Accurate Map of Pig Genome Gives Insights to Breeding Healthier Animals
- Scientists Develop Insulin-Deficient Pigs for Diabetes Research
- Scientists Use CRISPR to Grow Human Pancreas in Pigs
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- WHO Calls for Actions to Encourage Acceptance and Uptake of COVID-19 Vaccines
News from Around the World
- ISAAA Short Course Highlights Relevance of Integrating Research, Science-based Regulation, and SciCom in Sustainable Agri Dev't
- ISAAA Shares 2019 Global Biotech Crop Adoption to Stakeholders in the Philippines and Arab Region
- Give a Gift of Knowledge
- Webinar: Biotech Crop Adoption in 2019 and Latin America's Experience
- NBMA Validates National Biosafety Guidelines on Gene Editing in Nigeria
- University of Florida Study Uncovers Vanilla DNA Mystery
- RNAi Pesticides Could Be the Next Big Tool in Agriculture
- US FDA Has Approved First GM Pig for People with Red Meat Allergies
- Chinese Scientists Develop Rice Variety Using Ion Beam Technology
- GM Tomato Enriched with L-DOPA Offers Affordable Medicine for Parkinson's Disease
- Soybean Gene Overexpression Offers Resistance to SDS
Plant Breeding Innovations
- Biotech Research Perceived With Caution Globally, but Most Support Gene Editing for Therapeutics
Subscribe to CBU: